← Eichor
Condition: Covid19 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Covid19

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Covid-19 and Influenza Oral Vaccine Study
Phase 1 · 1 location(s) · Vaxine Pty Ltd · NCT06355232
Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COV
Phase 1 · 1 location(s) · The Methodist Hospital Research Institute · NCT06821100
Arginine Replacement Therapy in COVID-19
Phase 2 · 1 location(s) · Emory University · NCT05855330
Health Care Workers Cohort Study in the EuCARE Project (EuCARE-HCW)
Phase N/A · 7 location(s) · Euresist Network GEIE · NCT05534009
Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT06160128
Awake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy
NA · 38 location(s) · University Hospital, Tours · NCT06966310
tDCS in Post-Acute COVID-19 Patients With SARDs
NA · 1 location(s) · University of Sao Paulo · NCT04890483
Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19 and Non-COVID-19)
NA · 33 location(s) · Unity Health Toronto · NCT03963622
Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study)
Phase N/A · 1 location(s) · Instituto de Investigación Biomédica de Salamanca · NCT07295483
Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
Phase 1 · 1 location(s) · Stephanie B. Seminara, MD · NCT07224490
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Phase N/A · 1 location(s) · University of Oxford · NCT05571735
Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Phase 1 · 2 location(s) · Shionogi · NCT07093580
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Phase 4 · 6 location(s) · ModernaTX, Inc. · NCT06585241
Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
NA · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04558450
Evaluation of the Gambling Habits of Adolescents and Young Adults Post-COVID-19 and Implementation of a Digital Escape R
NA · 1 location(s) · Hospital Miguel Servet · NCT06904794
sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19
Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT07359482
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Phase 1/Phase 2 · 1 location(s) · Thomas Advanced Medical LLC · NCT04684602
Retrospective Analysis of Chest X-ray Severity Scoring System of COVID-19 Pneumonia
Phase N/A · 1 location(s) · Osijek University Hospital · NCT05181696
Evaluation of MicroRNAs and Vitamin B12 Expression in Subjects with Neurologic Symptoms of Depression, Anxiety and Fatig
Phase N/A · 1 location(s) · Instituto Nacional de Rehabilitacion · NCT06864156
Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05233605
The Role of Obesity in Severe COVID-19 Pathophysiology
NA · 1 location(s) · Franciscus Gasthuis · NCT06968442
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Phase 3 · 148 location(s) · Pfizer · NCT07013474
Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure
NA · 7 location(s) · Australian and New Zealand Intensive Care Research Centre · NCT05562505
Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04794829
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
NA · 4 location(s) · KidSIM Simulation Program · NCT05868239
Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
Phase N/A · 1 location(s) · The Geneva Foundation · NCT06402318
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
Phase N/A · 1 location(s) · BioCytics, Inc. · NCT00571389
COVID-19 Impact on RSV Emergency Presentations
Phase N/A · 1 location(s) · University Hospitals, Leicester · NCT04959734
Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
Phase 1/Phase 2 · 1 location(s) · All Natural Medicine Clinic, LLC · NCT04790240
Study of the Incidence of SARS-CoV-2 Infection (COVID-19)
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT04429594
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.